🟢 90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 20% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

2 Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
20% Evidence Coverage

Supplement Facts — Evidence Check

CogninSA
300 mg
Bacopin
200 mg
📊 Market median: 120.0mg (440 products) 📚 187 studies (Tier A: 1, B: 71)
This product: 120mg
Proprietary Brain Boosting Compound
200 mg
Futurebiotics BioAccelerators
23 mg

Other Ingredients

Modified Cellulose Stearic Acid Microcrystalline Cellulose Magnesium Stearate Mint Oil

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (80% of products) Nutrient (4% of products)

Target Groups

Vegetarian Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Directions: As a dietary supplement for adults, take 2 capsules daily, preferably with meals.

⚠️ Warnings & Precautions

Warning: Do not use if you are pregnant or nursing.

Keep out of reach of children.

Contains: Soy

🧪 Formulation Notes

This 100% vegetarian product has an aromatic botanical essence added, along with natural whole plant co-factors including Gotu Kola leaf, soy lecithin & rosemary.

This 100% vegetarian product has an aromatic botanical essence added, along with natural whole plant co-factors including Gotu Kola leaf, soy lecithin & rosemary.

100% Satisfaction Guaranteed

Brain performance + memory

Clinically studied nutrients for normal brain function

Additional Information

Protect from light.

Thinkfast - taking inspiration from Nature.

FutureBiotics Health. Nature. Life.

30 Days Supply

Product Details

UPC / SKU 0 49479 02509 1
DSLD Entry Date 2024-10-24
Product Type Other Combinations
Form Capsule
DSLD ID 319878
Data Updated 2026-04-11

Research Evidence

183 Research Sources
55 Avg Quality Score
86 Systematic Review
78 Meta Analysis
7 Other
4 Clinical Trial
2 Rct
2 Narrative Review
2 Regulatory Source
1 Openfda Safety
A Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2026
B Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2009
B Ginkgo biloba for tinnitus
Meta Analysis The Cochrane database of systematic reviews 2013
B Ginkgo biloba for tinnitus
Systematic Review The Cochrane database of systematic reviews 2022
B Ginkgo biloba for prevention of dementia: a randomized controlled trial
Rct JAMA 2008
B Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: A systematic review and meta-analysis
Systematic Review Frontiers in aging neuroscience 2023
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2013
B The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
Systematic Review Frontiers in aging neuroscience 2020
B Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2026
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2009
View all evidence for Ginkgo →

Compare Similar Products

View all Ginkgo products →